MedElevator Войти в исследования
← Поиск публикаций

DOI 10.12688/wellcomeopenres.17636.2

Медицинская библиотека · Wellcome open research · 2022

Efficiency of transplacental transfer of respiratory syncytial virus (RSV) specific antibodies among pregnant women in Kenya.

Nyiro Joyce U, Bukusi Elizabeth, Mwaengo Dufton, Nyaguara Amek, Nyawanda Bryan, Otieno Nancy, Bigogo Godfrey, Murunga Nickson, Widdowson Marc-Alain, Verani Jennifer R, Chaves Sandra S, Mwangudza Hope, Odundo Calleb, Berkley James A, Nokes D James, Munywoki Patrick K

СтатьяПеревод в очереди

Аннотация

Background

Maternal immunisation to boost respiratory syncytial virus (RSV) antibodies in pregnant women, is a strategy being considered to enhance infant protection from severe RSV associated disease. However, little is known about the efficiency of transplacental transfer of RSV-specific antibodies in a setting with a high burden of malaria and HIV, to guide the implementation of such a vaccination program.

Methods

Using a plaque reduction neutralization assay, we screened 400 pairs of cord and maternal serum specimens from pregnant women for RSV-specific antibodies. Participants were pregnant women of two surveillance cohorts: 200 participants from a hospital cohort in Kilifi, Coastal Kenya and 200 participants from a surveillance cohort in Siaya, Western Kenya. Transplacental transfer efficiency was determined by the cord to maternal titre ratio (CMTR). Logistic regression was used to determine independent predictors of impaired transplacental transfer of RSV-specific antibodies.

Results

A total of 800 samples were screened from the 400 participants. At enrollment the median age was 25 years (Interquartile range (IQR): 21-31). Overall, transplacental transfer was efficient and did not differ between Kilifi and Siaya cohort (1.02 vs. 1.02; p=0.946) but was significantly reduced among HIV-infected mothers compared to HIV-uninfected mothers (mean CMTR: 0.98 vs 1.03; p=0.015). Prematurity <33 weeks gestation (Odds ratio [OR]: 0.23, 95% confidence interval [CI] 0.06-0.85; p=0.028), low birth weight <2.5 kgs (OR: 0.25, 95% CI: 0.07-0.94; p=0.041) and HIV infection (OR: 0.47, 95% CI:0.23-0.98; p=0.045) reduced efficiency of transplacental transfer among these women.

Conclusions

Transplacental transfer of RSV-specific antibodies among pregnant women in Kenya is efficient. A consideration to integrate other preventive interventions with maternal RSV vaccination targeting infants born premature (<33 weeks gestation), with low birth weight <2.5 kgs, or HIV-infected mothers is likely to improve vaccine outcomes in this setting.

Для цитирования: Nyiro Joyce U, Bukusi Elizabeth, Mwaengo Dufton, Nyaguara Amek, Nyawanda Bryan, Otieno Nancy, Bigogo Godfrey, Murunga Nickson, Widdowson Marc-Alain, Verani Jennifer R, Chaves Sandra S, Mwangudza Hope, Odundo Calleb, Berkley James A, Nokes D James, Munywoki Patrick K. Efficiency of transplacental transfer of respiratory syncytial virus (RSV) specific antibodies among pregnant women in Kenya.. Wellcome open research. 2022. DOI: 10.12688/wellcomeopenres.17636.2.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.